Concepedia

Daniel M. Halperin

DM

Statistics

Publications

53

Citations

7.1K

H-Index

24

Active since

1998

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Dana-Farber Cancer Institute

Sunnybrook Health Science Centre

Moffitt Cancer Center

Fox Chase Cancer Center

Daniel M. Halperin is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, oncology, and neuroendocrine tumors.

ORCID

Publications per year

1998–2025

53

Publications

53

Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States

Arvind Dasari, Chan Shen, Daniel M. Halperin et al. · JAMA Oncology · 2017 · 3.5K citations · Full text

, , +17

Neuroendocrine and Adrenal Tumors, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology

Manisha H. Shah, Whitney Goldner, Al B. Benson et al. · Journal of the National Comprehensive Cancer Network · 2021 · 602 citations

, , +17

Ethyl pyruvate prevents lethality in mice with established lethal sepsis and systemic inflammation

Luis Ulloa, Mahendar Ochani, Huan Yang et al. · Proceedings of the National Academy of Sciences · 2002 · 592 citations · Full text

, , +17

NCCN Guidelines Insights: Neuroendocrine and Adrenal Tumors, Version 2.2018

Manisha H. Shah, Whitney Goldner, Þorvarður R. Hálfdánarson et al. · Journal of the National Comprehensive Cancer Network · 2018 · 391 citations · Full text

, , +17

Frequency of carcinoid syndrome at neuroendocrine tumour diagnosis: a population-based study

Daniel M. Halperin, Chan Shen, Arvind Dasari et al. · The Lancet Oncology · 2017 · 385 citations

, , +13

1–5 of 53